GSE195568 palbociclib 3 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE195568_palbociclib_3_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE195568_palbociclib_3_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE195568_palbociclib_3_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE195568_palbociclib_3_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MAGI2 antisense RNA 3

Gene

zinc finger protein 702, pseudogene

Gene

NF-kappaB interacting lncRNA

Gene

uncharacterized LOC100506076

Gene

HLA-F antisense RNA 1

Gene

nudix hydrolase 16 like 2, pseudogene

Gene

NINJ2 antisense RNA 1

Gene

EPB41L4A divergent transcript

Gene

SUGT1P4-STRA6LP readthrough

Gene

lncRNA upregulator of antiviral response interferon signaling

  • Gene

    MAGI2 antisense RNA 3


  • Gene

    zinc finger protein 702, pseudogene


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    uncharacterized LOC100506076


  • Gene

    HLA-F antisense RNA 1


  • Gene

    nudix hydrolase 16 like 2, pseudogene


  • Gene

    NINJ2 antisense RNA 1


  • Gene

    EPB41L4A divergent transcript


  • Gene

    SUGT1P4-STRA6LP readthrough


  • Gene

    lncRNA upregulator of antiviral response interferon signaling

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.